Adult hippocampal neurogenesis in Alzheimer's disease: A roadmap to clinical relevance.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 36736288.
- Also identified by DOI 10.1016/j.stem.2023.01.002 and PMC identifier 10082636.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Adult hippocampal neurogenesis (AHN) drops sharply during early stages of Alzheimer's disease (AD), via unknown mechanisms, and correlates with cognitive status in AD patients. Understanding AHN regulation in AD could provide a framework for innovative pharmacological interventions. We here combine molecular, behavioral, and clinical data and critically discuss the multicellular complexity of the AHN niche in relation to AD pathophysiology. We further present a roadmap toward a better understanding of the role of AHN in AD by probing the promises and caveats of the latest technological advancements in the field and addressing the conceptual and methodological challenges ahead.
Medical subject headings
- Alzheimer Disease